Fisetin induces the expression of tropomyosin-related kinase B (TrkB), brain-derived-neurotropic factor, PI3K-Akt, and ERK signaling pathways and inhibits the synthesis of inflammatory agents during the treatment of depression (Yu et al., 2016; Uddin et al., 2020). Here, NTRK2 is linked to major depressive disorder.